Top

Published in:

Open Access 01-06-2015 | Review

Infection homeostasis: implications for therapeutic and immune programming of metabolism in controlling infection

Authors: Konstantinos Kotzamanis, Ana Angulo, Peter Ghazal

Published in: Medical Microbiology and Immunology | Issue 3/2015

Abstract

Homeostasis underpins at a systems level the regulatory control of immunity and metabolism. While physiologically these systems are often viewed as independent, there is increasing evidence showing a tight coupling between immune and metabolic functions. Critically upon infection, the homeostatic regulation for both immune and metabolic pathways is altered yet these changes are often investigated in isolation. Here, we summarise our current understanding of these processes in the context of a clinically relevant pathogen, cytomegalovirus. We synthesise from the literature an integrative view of a coupled immune–metabolic infection process, centred on sugar and lipid metabolism. We put forward the notion that understanding immune control of key metabolic enzymatic steps in infection will promote the future development of novel therapeutic modalities based on metabolic modifiers that either enhance protection or inhibit infection.

Ghazal P, González Armas JC, García-Ramírez JJ et al (2000) Viruses: hostages to the cell. Virology 275:233–237. doi:10.1006/viro.2000.0553 PubMed

Redpath S, Angulo A, Gascoigne NR, Ghazal P (2001) Immune checkpoints in viral latency. Annu Rev Microbiol 55:531–560. doi:10.1146/annurev.micro.55.1.531 PubMed

Ghazal P, García-Ramírez J, González-Armas JC et al (2000) Principles of homeostasis in governing virus activation and latency. Immunol Res 21:219–223. doi:10.1385/IR:21:2-3:219 PubMed

Holthuis JCM, Menon AK (2014) Lipid landscapes and pipelines in membrane homeostasis. Nature 510:48–57. doi:10.1038/nature13474 PubMed

Jeon T, Il Osborne TF (2012) SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab 23:65–72. doi:10.1016/j.tem.2011.10.004 PubMedCentralPubMed

Palazon A, Goldrath AW, Nizet V, Johnson RS (2014) Review HIF transcription factors, inflammation, and immunity. Immunity 41:518–528. doi:10.1016/j.immuni.2014.09.008 PubMed

McNelis J, Olefsky J (2014) Macrophages, immunity, and metabolic disease. Immunity 41:36–48. doi:10.1016/j.immuni.2014.05.010 PubMed

Maceyka M, Spiegel S (2014) Sphingolipid metabolites in inflammatory disease. Nature 510:58–67. doi:10.1038/nature13475 PubMedCentralPubMed

Everts B, Pearce EJ (2014) Metabolic control of dendritic cell activation and function: recent advances and clinical implications. Front Immunol 5:1–7. doi:10.3389/fimmu.2014.00203

10.

Cyster JG, Dang EV, Reboldi A, Yi T (2014) 25-Hydroxycholesterols in innate and adaptive immunity. Nat Rev Immunol 14:731–743. doi:10.1038/nri3755 PubMed

11.

Koyuncu E, Purdy JG, Rabinowitz JD, Shenk T (2013) Saturated very long chain fatty acids are required for the production of infectious human cytomegalovirus progeny. PLoS Pathog 9:e1003333. doi:10.1371/journal.ppat.1003333 PubMedCentralPubMed

12.

Moser TS, Schieffer D, Cherry S (2012) AMP-activated kinase restricts Rift Valley fever virus infection by inhibiting fatty acid synthesis. PLoS Pathog 8:e1002661. doi:10.1371/journal.ppat.1002661 PubMedCentralPubMed

13.

Zheng Y-H, Plemenitas A, Fielding CJ, Peterlin BM (2003) Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions. Proc Natl Acad Sci USA 100:8460–8465. doi:10.1073/pnas.1437453100 PubMedCentralPubMed

14.

Vastag L, Koyuncu E, Grady SL et al (2011) Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism. PLoS Pathog 7:e1002124. doi:10.1371/journal.ppat.1002124 PubMedCentralPubMed

15.

Blanc M, Hsieh WY, Robertson KA et al (2011) Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis. PLoS Biol 9:e1000598. doi:10.1371/journal.pbio.1000598 PubMedCentralPubMed

16.

Blanc M, Hsieh WY, Robertson KA et al (2013) The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response. Immunity 38:106–118. doi:10.1016/j.immuni.2012.11.004 PubMedCentralPubMed

17.

Deberardinis RJ, Sayed N, Ditsworth D, Thompson CB (2008) Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 18:54–61. doi:10.1016/j.gde.2008.02.003 PubMedCentralPubMed

18.

Vander Heiden MG, Locasale JW, Swanson KD et al (2010) Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 329:1492–1499. doi:10.1126/science.1188015 PubMed

19.

DeBerardinis RJ, Mancuso A, Daikhin E et al (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA 104:19345–19350. doi:10.1073/pnas.0709747104 PubMedCentralPubMed

20.

Kim J, Dang CV (2006) Cancer’s molecular sweet tooth and the Warburg effect. Cancer Res 66:8927–8930. doi:10.1158/0008-5472.CAN-06-1501 PubMed

21.

Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033. doi:10.1126/science.1160809 PubMedCentralPubMed

22.

Menendez JA, Lupu R (2007) Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7:763–777. doi:10.1038/nrc2222 PubMed

23.

Swinnen JV, Brusselmans K, Verhoeven G (2006) Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care 9:358–365. doi:10.1097/01.mco.0000232894.28674.30 PubMed

24.

Munger J, Bajad SU, Coller HA et al (2006) Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog 2:e132. doi:10.1371/journal.ppat.0020132 PubMedCentralPubMed

25.

Munger J, Bennett BD, Parikh A et al (2008) Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat Biotechnol 26:1179–1186. doi:10.1038/nbt.1500 PubMedCentralPubMed

26.

Yu Y, Clippinger AJ, Alwine JC (2011) Viral effects on metabolism: changes in glucose and glutamine utilization during human cytomegalovirus infection. Trends Microbiol 19:360–367. doi:10.1016/j.tim.2011.04.002 PubMedCentralPubMed

27.

McArdle J, Moorman NJ, Munger J (2012) HCMV targets the metabolic stress response through activation of AMPK whose activity is important for viral replication. PLoS Pathog 8:e1002502. doi:10.1371/journal.ppat.1002502 PubMedCentralPubMed

28.

Yu Y, Pierciey FJ, Maguire TG, Alwine JC (2013) PKR-like endoplasmic reticulum kinase is necessary for lipogenic activation during HCMV infection. PLoS Pathog 9(9):e1003266. doi:10.1371/journal.ppat.1003266 PubMedCentralPubMed

29.

Yu Y, Maguire TG, Alwine JC (2012) Human cytomegalovirus infection induces adipocyte-like lipogenesis through activation of sterol regulatory element binding protein 1. J Virol 86:2942–2949. doi:10.1128/JVI.06467-11 PubMedCentralPubMed

30.

Yu Y, Maguire TG, Alwine JC (2014) ChREBP, a glucose-responsive transcriptional factor, enhances glucose metabolism to support biosynthesis in human cytomegalovirus-infected cells. Proc Natl Acad Sci USA 111:1951–1956. doi:10.1073/pnas.1310779111 PubMedCentralPubMed

31.

Yu Y, Maguire TG, Alwine JC (2011) Human cytomegalovirus activates glucose transporter 4 expression to increase glucose uptake during infection. J Virol 85:1573–1580. doi:10.1128/JVI.01967-10 PubMedCentralPubMed

32.

Chambers JW, Maguire TG, Alwine JC (2010) Glutamine metabolism is essential for human cytomegalovirus infection. J Virol 84:1867–1873. doi:10.1128/JVI.02123-09 PubMedCentralPubMed

33.

Seo J-Y, Cresswell P (2013) Viperin regulates cellular lipid metabolism during human cytomegalovirus infection. PLoS Pathog 9:e1003497. doi:10.1371/journal.ppat.1003497 PubMedCentralPubMed

34.

Seo J-Y, Yaneva R, Cresswell P (2011) Viperin: a multifunctional, interferon-inducible protein that regulates virus replication. Cell Host Microbe 10:534–539. doi:10.1016/j.chom.2011.11.004 PubMedCentralPubMed

35.

Seo J-Y, Yaneva R, Hinson ER, Cresswell P (2011) Human cytomegalovirus directly induces the antiviral protein viperin to enhance infectivity. Science 332:1093–1097. doi:10.1126/science.1202007 PubMed

36.

Spencer CM, Schafer XL, Moorman NJ, Munger J (2011) Human cytomegalovirus induces the activity and expression of acetyl-coenzyme A carboxylase, a fatty acid biosynthetic enzyme whose inhibition attenuates viral replication. J Virol 85:5814–5824. doi:10.1128/JVI.02630-10 PubMedCentralPubMed

37.

Radsak KD, Weder D (1981) Effect of 2-deoxy-d-glucose on cytomegalovirus-induced DNA synthesis in human fibroblasts. J Gen Virol 57:33–42PubMed

38.

Ghesquière B, Wong BW, Kuchnio A, Carmeliet P (2014) Metabolism of stromal and immune cells in health and disease. Nature 511:167–176. doi:10.1038/nature13312 PubMed

39.

Pearce EL (2010) Metabolism in T cell activation and differentiation. Curr Opin Immunol 22:314–320. doi:10.1016/j.coi.2010.01.018 PubMed

40.

Chang C-H, Curtis JD, Maggi LB et al (2013) Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153:1239–1251. doi:10.1016/j.cell.2013.05.016 PubMedCentralPubMed

41.

Pearce EL, Poffenberger MC, Chang C-H, Jones RG (2013) Fueling immunity: insights into metabolism and lymphocyte function. Science 342:1242454. doi:10.1126/science.1242454 PubMed

42.

Pearce EL, Pearce EJ (2013) Metabolic pathways in immune cell activation and quiescence. Immunity 38:633–643. doi:10.1016/j.immuni.2013.04.005 PubMedCentralPubMed

43.

Rodríguez-Prados J-C, Través PG, Cuenca J et al (2010) Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol 185:605–614. doi:10.4049/jimmunol.0901698 PubMed

44.

Everts B, Amiel E, van der Windt GJW et al (2012) Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. Blood 120:1422–1431. doi:10.1182/blood-2012-03-419747 PubMedCentralPubMed

45.

West AP, Brodsky IE, Rahner C et al (2011) TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 472:476–480. doi:10.1038/nature09973 PubMedCentralPubMed

46.

Krawczyk CM, Holowka T, Sun J et al (2010) Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115:4742–4749. doi:10.1182/blood-2009-10-249540 PubMedCentralPubMed

47.

Everts B, Amiel E, Huang SC-C et al (2014) TLR-driven early glycolytic reprogramming via the kinases TBK1-IKK[epsiv] supports the anabolic demands of dendritic cell activation. Nat Immunol 15:323–332. doi:10.1038/ni.2833 PubMedCentralPubMed

48.

Galván-Peña S, O’Neill LAJ (2014) Metabolic reprogramming in macrophage polarization. Front Immunol 5:1–6. doi:10.3389/fimmu.2014.00420

49.

McGettrick AF, O’Neill LAJ (2013) How metabolism generates signals during innate immunity and inflammation. J Biol Chem 288:22893–22898. doi:10.1074/jbc.R113.486464 PubMedCentralPubMed

50.

Freemerman AJ, Johnson AR, Sacks GN et al (2014) Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. J Biol Chem 289:7884–7896. doi:10.1074/jbc.M113.522037 PubMedCentralPubMed

51.

Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9:139–150. doi:10.1038/nrm2329 PubMed

52.

Angulo A, Suto C, Boehm MF et al (1995) Retinoid activation of retinoic acid receptors but not of retinoid X receptors promotes cellular differentiation and replication of human cytomegalovirus in embryonal cells. J Virol 69:3831–3837PubMedCentralPubMed

53.

Ghazal P, DeMattei C, Giulietti E et al (1992) Retinoic acid receptors initiate induction of the cytomegalovirus enhancer in embryonal cells. Proc Natl Acad Sci USA 89:7630–7634. doi:10.1073/pnas.89.16.7630 PubMedCentralPubMed

54.

Angulo A, Chandraratna RA, LeBlanc JF, Ghazal P (1998) Ligand induction of retinoic acid receptors alters an acute infection by murine cytomegalovirus. J Virol 72:4589–4600PubMedCentralPubMed

55.

Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497–509. doi:10.1371/journal.pone.0020510 PubMed

56.

Jakobsson A, Westerberg R, Jacobsson A (2006) Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog Lipid Res 45:237–249. doi:10.1016/j.plipres.2006.01.004 PubMed

57.

Liu STH, Sharon-Friling R, Ivanova P et al (2011) Synaptic vesicle-like lipidome of human cytomegalovirus virions reveals a role for SNARE machinery in virion egress. Proc Natl Acad Sci USA 108:12869–12874. doi:10.1073/pnas.1109796108 PubMedCentralPubMed

58.

Alwine JC (2012) The human cytomegalovirus assembly compartment: a masterpiece of viral manipulation of cellular processes that facilitates assembly and egress. PLoS Pathog 8:e1002878. doi:10.1371/journal.ppat.1002878 PubMedCentralPubMed

59.

Das S, Pellett PE (2007) Members of the HCMV US12 family of predicted heptaspanning membrane proteins have unique intracellular distributions, including association with the cytoplasmic virion assembly complex. Virology 361:263–273. doi:10.1016/j.virol.2006.11.019 PubMed

60.

Das S, Pellett PE (2011) Spatial relationships between markers for secretory and endosomal machinery in human cytomegalovirus-infected cells versus those in uninfected cells. J Virol 85:5864–5879. doi:10.1128/JVI.00155-11 PubMedCentralPubMed

61.

Das S, Vasanji A, Pellett PE (2007) Three-dimensional structure of the human cytomegalovirus cytoplasmic virion assembly complex includes a reoriented secretory apparatus. J Virol 81:11861–11869. doi:10.1128/JVI.01077-07 PubMedCentralPubMed

62.

Zelcer N, Tontonoz P (2006) Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 116:607–614. doi:10.1172/JCI27883 PubMedCentralPubMed

63.

Castrillo A, Joseph SB, Vaidya SA et al (2003) Crosstalk between LXR and Toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell 12:805–816. doi:10.1016/S1097-2765(03)00384-8 PubMed

64.

Wang S, Wu D, Lamon-Fava S et al (2009) In vitro fatty acid enrichment of macrophages alters inflammatory response and net cholesterol accumulation. Br J Nutr 102:497–501. doi:10.1017/S0007114509231758 PubMedCentralPubMed

65.

Ecker J, Liebisch G, Englmaier M et al (2010) Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes. Proc Natl Acad Sci USA 107:7817–7822. doi:10.1073/pnas.0912059107 PubMedCentralPubMed

66.

Shibata N, Carlin AF, Spann NJ et al (2013) 25-Hydroxycholesterol activates the integrated stress response to reprogram transcription and translation in macrophages. J Biol Chem 288:35812–35823. doi:10.1074/jbc.M113.519637 PubMedCentralPubMed

67.

Browne EP, Wing B, Coleman D, Shenk T (2001) Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. J Virol 75:12319–12330. doi:10.1128/JVI.75.24.12319-12330.2001 PubMedCentralPubMed

68.

Simmen KA, Singh J, Luukkonen BG et al (2001) Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc Natl Acad Sci USA 98:7140–7145. doi:10.1073/pnas.121177598 PubMedCentralPubMed

69.

AbuBakar S, Boldogh I, Albrecht T (1990) Human cytomegalovirus stimulates arachidonic acid metabolism through pathways that are affected by inhibitors of phospholipase A2 and protein kinase C. Biochem Biophys Res Commun 166:953–959. doi:10.1016/0006-291X(90)90903-Z PubMed

70.

Bos CL, Richel DJ, Ritsema T et al (2004) Prostanoids and prostanoid receptors in signal transduction. Int J Biochem Cell Biol 36:1187–1205. doi:10.1016/j.biocel.2003.08.006 PubMed

71.

Schröer J, Shenk T (2008) Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirus. Proc Natl Acad Sci USA 105:19468–19473. doi:10.1073/pnas.0810740105 PubMedCentralPubMed

72.

Zhu H, Cong J-P, Yu D et al (2002) Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc Natl Acad Sci USA 99:3932–3937. doi:10.1073/pnas.052713799 PubMedCentralPubMed

73.

Lee KJ, Angulo A, Ghazal P, Janda KD (1999) Soluble-polymer supported synthesis of a prostanoid library: identification of antiviral activity. Org Lett 1:1859–1862PubMed

74.

Sirois P, Cadieux A, Rola-Pleszczynski M, Bégin R (1982) Perifused alveolar macrophages. A technique to study the effects of toxicants on prostaglandin release. Experientia 38:1125–1127. doi:10.1007/BF01955404 PubMed

75.

Infantino V, Convertini P, Cucci L et al (2011) The mitochondrial citrate carrier: a new player in inflammation. Biochem J 438:433–436. doi:10.1042/BJ20111275 PubMed

76.

Dennis EA, Deems RA, Harkewicz R et al (2010) A mouse macrophage lipidome. J Biol Chem 285:39976–39985. doi:10.1074/jbc.M110.182915 PubMedCentralPubMed

77.

Biswas SK, Mantovani A (2012) Orchestration of metabolism by macrophages. Cell Metab 15:432–437. doi:10.1016/j.cmet.2011.11.013 PubMed

78.

Hirata T, Narumiya S (2012) Prostanoids as regulators of innate and adaptive immunity. Adv Immunol 116:143–174. doi:10.1016/B978-0-12-394300-2.00005-3 PubMed

79.

Martinez FO, Gordon S, Locati M, Mantovani A (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 177:7303–7311. doi:10.1016/S1077-9108(08)70760-6 PubMed

80.

Mosca M, Polentarutti N, Mangano G et al (2007) Regulation of the microsomal prostaglandin E synthase-1 in polarized mononuclear phagocytes and its constitutive expression in neutrophils. J Leukoc Biol 82:320–326. doi:10.1189/jlb.0906576 PubMed

81.

Diaz-Munoz MD, Osma-Garcia IC, Fresno M, Iniguez MA (2012) Involvement of PGE2 and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-activated macrophages. Biochem J 443:451–461. doi:10.1042/BJ20111052 PubMed

82.

Nataraj C, Thomas DW, Tilley SL et al (2001) Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse. J Clin Invest 108:1229–1235. doi:10.1172/JCI13640 (Introduction)PubMedCentralPubMed

83.

Vassiliou E, Jing H, Ganea D (2003) Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells. Cell Immunol 223:120–132. doi:10.1016/S0008-8749(03)00158-8 PubMed

84.

Harizi H, Grosset C, Gualde N (2003) Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes. J Leukoc Biol 73:756–763. doi:10.1189/jlb.1002483 PubMed

85.

Yao C, Sakata D, Esaki Y et al (2009) Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat Med 15:633–640. doi:10.1038/nm.1968 PubMed

86.

Nokta MA, Hassan MI, Loesch K, Pollard RB (1996) Human cytomegalovirus-induced immunosuppression relationship to prostaglandin E2 in human monocytes. J Clin Invest 97:2635–2641PubMedCentralPubMed

87.

Ogawa S, Lozach J, Benner C et al (2005) Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122:707–721. doi:10.1016/j.cell.2005.06.029 PubMedCentralPubMed

88.

Lees RS, Fiser RH, Beisel WR, Bartelloni PJ (1972) Effects of an experimental viral infection on plasma lipid and lipoprotein metabolism. Metabolism 21:825–833PubMed

89.

Sole A (1956) Serum cholesterol in measles. Arch Kinderheilkd 152:127–135PubMed

90.

Viikari J, Ruuskanen O, Salmi T, Halonen P (1979) Effect of measles and measles vaccine on serum-cholesterol. Lancet 1:326. doi:10.1016/S0140-6736(79)90738-4 PubMed

91.

Isaacs A, Lindenmann J (1957) Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147:258–267PubMed

92.

Cantell K, Ehnholm C, Mattila K, Kostiainen E (1980) Interferon and high-density lipoproteins. N Engl J Med 302:1032–1033. doi:10.1056/NEJM198005013021817 PubMed

93.

Rosenzweig IB, Wiebe DA, Borden EC et al (1987) Plasma lipoprotein changes in humans induced by beta-interferon. Atherosclerosis 67:261–267PubMed

94.

Schectman G, Kaul S, Mueller RA et al (1992) The effect of interferon on the metabolism of LDLs. Arterioscler Thromb 12:1053–1062. doi:10.1161/01.ATV.12.9.1053 PubMed

95.

Borden EC, Rinehart JJ, Storer BE et al (1990) Biological and clinical effects of interferon-beta ser at two doses. J Interferon Res 10:559–570PubMed

96.

Shope RE (1930) Variations in the plasma cholesterol and cholesterol ester content in hog cholera. J Exp Med 51:179–187PubMedCentralPubMed

97.

Iqbal M, Grand NG (1973) Biochemical events in murine cytomegalovirus-infected mouse liver. Proc Soc Exp Biol Med 142:567–571PubMed

98.

Ponroy N, Taveira A, Mueller NJ, Millard AL (2015) Statins demonstrate a broad anti-cytomegalovirus activity in vitro in ganciclovir-susceptible and resistant strains. J Med Virol. doi:10.1002/jmv.23998 PubMed

99.

Potena L, Frascaroli G, Grigioni F et al (2004) Hydroxymethyl-glutaryl coenzyme A reductase inhibition limits cytomegalovirus infection in human endothelial cells. Circulation 109:532–536. doi:10.1161/01.CIR.0000109485.79183.81 PubMed

100.

Murayama T, Bi C, Li Y et al (2011) Inhibitory effects of statins on cytomegalovirus production in human cells: comprehensive analysis of gene expression profiles. J Exp Clin Med 3:40–45. doi:10.1016/j.jecm.2010.12.009

101.

Watterson S, Guerriero ML, Blanc M et al (2013) A model of flux regulation in the cholesterol biosynthesis pathway: immune mediated graduated flux reduction versus statin-like led stepped flux reduction. Biochimie 95:613–621. doi:10.1016/j.biochi.2012.05.024 PubMedCentralPubMed

102.

Gudleski-O’Regan N, Greco TM, Cristea IM, Shenk T (2012) Increased expression of LDL receptor-related protein 1 during human cytomegalovirus infection reduces virion cholesterol and infectivity. Cell Host Microbe 12:86–96. doi:10.1016/j.chom.2012.05.012 PubMedCentralPubMed

103.

Liu S-Y, Aliyari R, Chikere K et al (2012) Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity 38:92–105. doi:10.1016/j.immuni.2012.11.005 PubMedCentralPubMed

104.

Preuss I, Ludwig M-G, Baumgarten B et al (2014) Transcriptional regulation and functional characterization of the oxysterol/EBI2 system in primary human macrophages. Biochem Biophys Res Commun 446:663–668. doi:10.1016/j.bbrc.2014.01.069 PubMed

105.

Lu H, Talbot S, Robertson KA et al (2015) Rapid proteasomal elimination of 3-hydroxy-3-methylglutaryl-coenzyme A reductase by interferon-gamma in primary macrophages requires endogenous 25-hydroxycholesterol synthesis. Steroids. doi:10.1016/j.steroids.2015.02.022

106.

Reboldi A, Dang EV, McDonald JG et al (2014) 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon. Science 345:679–684. doi:10.1126/science.1254790 PubMedCentralPubMed

107.

Ghazal P, Watterson S, Robertson K, Kluth DC (2011) The in silico macrophage: toward a better understanding of inflammatory disease. Genome Med 3:1–7. doi:10.1186/gm218

108.

Burrack KS, Morrison TE (2014) The role of myeloid cell activation and arginine metabolism in the pathogenesis of virus-induced diseases. Front Immunol 5:1–12. doi:10.3389/fimmu.2014.00428

109.

Heseler K, Schmidt SK, Spekker K et al (2013) Cytomegalovirus impairs the induction of indoleamine 2,3-dioxygenase mediated antimicrobial and immunoregulatory effects in human fibroblasts. PLoS ONE 8:1–7. doi:10.1371/journal.pone.0064442

Title: Infection homeostasis: implications for therapeutic and immune programming of metabolism in controlling infection
Authors: Konstantinos Kotzamanis
Ana Angulo
Peter Ghazal
Publication date: 01-06-2015
Publisher: Springer Berlin Heidelberg
Published in: Medical Microbiology and Immunology / Issue 3/2015
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI: https://doi.org/10.1007/s00430-015-0402-5

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Infection homeostasis: implications for therapeutic and immune programming of metabolism in controlling infection

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2015

Stepwise adaptation of murine cytomegalovirus to cells of a foreign host for identification of host range determinants

Human cytomegalovirus: taking the strain

Sepsis and cytomegalovirus: foes or conspirators?

Mechanism of tumor remission by cytomegalovirus in a murine lymphoma model: evidence for involvement of virally induced cellular interleukin-15

Principles for studying in vivo attenuation of virus mutants: defining the role of the cytomegalovirus gH/gL/gO complex as a paradigm

The history of vaccination against cytomegalovirus

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page